Terms: = Head and neck cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Prognosis
10 results:
1. Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population.
Gogolewska M; Kabziński J; Majsterek I
Int J Occup Med Environ Health; 2023 Dec; 36(6):812-824. PubMed ID: 38099560
[TBL] [Abstract] [Full Text] [Related]
2. Nutritional intervention for the prognosis of nasopharyngeal carcinoma chemoradiotherapy patients: A meta-analysis.
He Y; Chen X; Yang T; Li Y; Tan S; Liu X
Medicine (Baltimore); 2023 Oct; 102(41):e35386. PubMed ID: 37832079
[TBL] [Abstract] [Full Text] [Related]
3. The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma.
Tsai MH; Chuang HC; Lin YT; Yang KL; Lu H; Huang TL; Tsai WL; Su YY; Fang FM
Technol Cancer Res Treat; 2022; 21():15330338221141254. PubMed ID: 36426570
[No Abstract] [Full Text] [Related]
4. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic factors for incomplete response in thyroid microcarcinoma: an analysis of initial response to therapy in 517 patients.
Faro FN; Simões VRF; Ricardo GP; Cabral CP; de Cássia Braga Ribeiro K; Scalissi NM; Cury AN; Marone MM; do Prado Padovani R; Ferraz C
Arch Endocrinol Metab; 2021 Oct; 65(5):579-587. PubMed ID: 33740337
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract] [Full Text] [Related]
8. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings.
Park YJ; Kim YA; Lee YJ; Kim SH; Park SY; Kim KW; Chung JK; Youn YK; Kim KH; Park DJ; Cho BY
Head Neck; 2010 Jan; 32(1):38-45. PubMed ID: 19475551
[TBL] [Abstract] [Full Text] [Related]
9. Cost effectiveness of detecting Barrett's cancer.
Wright TA; Gray MR; Morris AI; Gilmore IT; Ellis A; Smart HL; Myskow M; Nash J; Donnelly RJ; Kingsnorth AN
Gut; 1996 Oct; 39(4):574-9. PubMed ID: 8944568
[TBL] [Abstract] [Full Text] [Related]
10. Are the new staging rules better for T4 oral cancer?
Virag M; Uglesić V; Aljinovíc N; Jurlina M
Am J Surg; 1995 Nov; 170(5):432-5. PubMed ID: 7485726
[TBL] [Abstract] [Full Text] [Related]
